|
(MoneyNewsWire.Net, September 25, 2017 ) The Asia-Pacific Therapeutic Vaccines Market which is estimated at $223.11 Million in 2016, is poised to reach $1120.65 Million by 2021 with a CAGR of 38.1%. Therapeutic vaccines are biologicals which are intended to treat a viral infection by stimulating the immune system
View Full Report @ http://www.marketdataforecast.com/market-reports/asia-pacific-therapeutic-vaccines-market-77/
The therapeutic vaccine Market is different from any other product market. Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. Coming to the Asian Market Yisheng Biopharma, in China, has developed a new vaccine for the post exposure treatment of the rabies infection and is set to enter human clinical trial after a six-year collaboration with research institutes worldwide. In India, Bharat Biotech, claimed to have achieved a breakthrough in developing a vaccine to fight the deadly Zika virus, which causes serious birth defects in children.
Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-therapeutic-vaccines-market-77/request-sample
Coming to the Segmentation, The Asia-Pacific Therapeutic Vaccines Market is categorized by the type of disease into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, on the basis of geography, the Asia-Pacific Market is segmented and analysed at country level under various regions namely, India, China, Japan and South Korea.
Some of the key players influencing the Asia-Pacific preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.
Market Segmentation
1) By Disease Type
• Autoimmune Disease Vaccines
• Cancer Vaccines
• Multikine
• PR1 Peptide
• TroVax
• CYT004-MelQbG10
• Neurological Disease Vaccines
ACC- 001
CAD 106
Parkinson’s disease Vaccine
Alzheimer’s disease
• Infectious Disease Vaccines
Hepatitis C
HIV/AIDS
Other Infectious Disease
Inquire before Buying at http://www.marketdataforecast.com/market-reports/asia-pacific-therapeutic-vaccines-market-77/inquire
Reasons to buy Asia-Pacific Therapeutic Vaccines Market Research Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
